Hormone replacement therapy and lipid metabolism in women on hemodialysis with secondary to uremia estrogen deficiency;Hormonalna terapia zastepcza a gospodarka lipidowa u kobiet dializowanych z wtornym do mocznicy niedoborem estrogenow

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 2, 1999, Pages 671-676

  Matuszkiewicz Rowińska, Joanna ^a   Skórzewska, Katarzyna ^b   Radowicki, Stanisław ^b   Sokalski, Antoni ^c   Niemczyk, Stanisław ^c   Wardyn, Kazimierz ^a   Bijak, Krzysztof ^a   Przedlacki, Jerzy ^a   Ostrowski, Kazimierz ^a  

^a Pneumonologii i Alergol A M w W   (Poland)

^b AM   (Poland)

^c Osrodek Dializ Szpitala w Radomiu ^*

Author keywords

End stage renal disease; HDL cholesterol; Hemodialysis; Hormonal replacement therapy; LDL cholesterol; Triglycerides

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; HEMODIALYSIS; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; PREMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL; UREMIA;

EID: 0033507826     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ginsburg E., Price D., Chertow G. i wsp.: Estrogen replacement therapy for cardiovascular risk in postmenopausal women with ESRD (Abstract). Am. Soc. Nephrol., 1996, A0995.
2. Zdrojewski Z, Rutkowski B.: Zaburzenia przemiany białkowej, wȩglowodanowej i lipidowej. W: Dializoterapia w codziennej praktyce. Red. Rudkowski B., MAKmed., Gdańsk, 1996, 354.
3. Lazarus J.M., Denker B.M., Owen W.F.: Hemodialysis. In: The Kidney. Ed.: Brenner B.M., W.B. Saunders Co, Philadelphia, 1996, 2424.
4. Stampfer M.J., Colditz G.A., Willett W.C. i wsp.: Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N. Engl. J. Med., 1991, 325, 756.
5. Bush T.L., Barret-Connor E., Cowan L.D. i wsp.: Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation, 1987, 75, 1102.
6. Psaty B.M., Hackbert S.R., Atkins D. i wsp.: The risk of myocardial infarction associated with the combined use of estrogen and progrestin in postmenopausal women. Arch. Intern. Med., 1994, 154, 1333.
7. Kim J.C., Jang H.C., Cho D.H. i wsp.: Effects of hormone replacement therapy on lipoproteins and lipids in postmenopausal women. Arterioscler. Thromb., 1994, 14, 275.
8. Walsh B.W., Schiff I., Rosner B. i wsp.: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma liproteins. N. Engl. J. Med., 1991, 325, 1196.
9. Tuck C.H., Holieran S., Berglund L.: Hormonal regulation of lipoprotein (a) levels; effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1822.
10. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA, 1993, 269, 3015.
11. Holley J.L., Schmidt R.J., Bender F.H., Dumler F., Schiff M.: Gynecologic and reproductive issues in women on dialysis. Am. J. Kidney Dis., 1997, 29, 685.
12. Holley J.L., Schmidt R.J., Bender F.H., Dumler F., Schiff M.: Menstruation, sexual activity, and contraception in women on dialysis (Abstract). Am. Soc. Nephrol., 1996, A1004.
13. Friedewald W.T., Levy R.J., Fredrickson D.S.: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem., 1972, 18, 499.
14. Petitti D.B., Wingerd J., Pellegrin F., Ramcharan S.: Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptives estrogens, and other factors. JAMA, 1979, 242, 1150.
15. Udoff L., Langenberg P., Adashi E.Y.: Combined continuous hormone replacement therapy: A critical review. Obstet. Gynecol., 1995, 86, 306.
16. Darling G.M., Johns J.A., McCloud P.I., Davis S.R.: Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women. N. Engl. J. Med., 1997, 337, 595.
17. Crook D., Cust M.P., Gangar K.F.: Comparison of transdermal and oral estrogen-progestin replacement therapy: Effects on serum lipids and lipoproteins. Am. J. Obstet. Gynecol., 1992, 166, 950.
18. Joles J.A., Bijleveld C., van Tol A., Geelen M.J.H., Koomans H.A.,: Estradiol fails to reduce LDL cholesterol and fibrynogen and exacerbates hypertriglyceridemia in ovariectomized rats (Abstract). Am. Soc. Nephrol., 1996, A3048.